Disclaimers. Opioid Dependence: Before, During and After Pregnancy WHY TALK ABOUT THIS? WHY TALK ABOUT THIS? WHY TALK ABOUT THIS?
|
|
- Dominick Strickland
- 8 years ago
- Views:
Transcription
1 : Before, During and After Pregnancy Carl Christensen, MD, PhD, FASAM, FACOG Past President, Mich Society Addiction Medicine Medical Director, Eleonore Hutzel Recovery Center, DMC Clinical Associate Professor, WSU Pain Recovery Solutions Ann Arbor, MI Disclaimers Consultant, PCSS Consultant, DEA/ DOJ Consultant, BCBS Speaker, Reckitt Benckiser Methadone provider, WSU Former: Medical Director, Dawn Farm WHY TALK ABOUT THIS? James Wardell, MD Medical Director, Eleonore Hutzel Recovery Center (EHRC) Addiction and Pregnancy 3 Addiction and Pregnancy 4 WHY TALK ABOUT THIS? WHY TALK ABOUT THIS? Addiction and Pregnancy 5 Addiction and Pregnancy 6 Carl Christensen, MD PhD 1
2 What is Addiction? What is Addiction? Physiologic Dependence? Lack of willpower? An amoral condition? A mental illness? Physiology of Addiction 9 Physiologic Dependence: Tolerance and Withdrawal The Nucleus Accumbens: GO!!! Tolerance: requiring increasing amounts of drug to get the same effect Withdrawal: the opposite effect of the drug when it is removed NEITHER of these imply chemical dependency (addiction) Physiology of Addiction 10 Physiology of Addiction 14 VTA: the gas tank : supplies dopamine to the Nucleus Accumbens Frontal Cortex: STOP!!!! Physiology of Addiction 15 Physiology of Addiction 16 Carl Christensen, MD PhD 2
3 What is Addiction? What is Addiction? Addiction is not a problem of drug WITHDRAWAL.. It is a problem of: CRAVING LOSS OF CONTROL COMPULSIVE USE USE DESPITE CONSEQUENCES WHY CAN T ADDICTS STOP? I feel like I don t belong in my own skin. anonymous alcoholic Decreased Dopamine receptors =decreased Dopamine = Decreased Hedonic Tone Salsitz 2006 Physiology of Addiction 21 Grand Physiology Rounds of Hutzel Addiction SAFETY OF OPIOIDS IN CHRONIC PAIN MANAGEMENT Are opioids the culprit? Risks factors in opioid deaths in WV HALL et al, JAMA Dec ; 300; 22: 2613 Risk Factor History of drug abuse 78 Any diverted meds 63 Nonmedical route 22 5 Providers 21 Alcohol 17 History of previous OD 17 Illicit drug (Coc, H, meth) 16 Currently enrolled in OTP 4 Percentage involved 36 ANY INDICATOR Carl Christensen, MD PhD 3
4 Are opioids the culprit? Risks factors in opioid deaths 4 prescriptions, 4 providers; dead from overdose...opioid analgesics were involved in 75% of pharmaceutical overdose deaths; benzodiazepines were also involved in 29% of such deaths. Benzodiazepines were also involved in 30% of opioid-related deaths-far more than any other class of drugs. This indicates that combining benzos and opioids may be especially dangerous WHY do doctors over prescribe? The Four D s: Dated Dishonest Duped Disabled 42 Addiction and Pregnancy 43 How to Report Allegation Unit Bureau of Health Care Services P.O. Box Lansing, (517) Michigan Health Professionals Recovery Program ADDICTION PAIN How do you recognize when you are fueling addiction rather than treating pain? Making the Diagnosis Carl Christensen, MD PhD 4
5 Techniques to Evaluate for signs of addiction in your pain patient Techniques to Evaluate for signs of addiction in your pain patient Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability Techniques to Evaluate for signs of addiction in your pain patient Urine Drug Screens Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability Check for meds that you have been prescribing. (missing meds = malingering) Check for meds that indicate abuse (MJ, cocaine) = addiction Remember your medication may not show up (methadone, fentanyl, suboxone) TELL THE PATIENT YOU ARE TESTING THEM FOR SAFETY S SAKE TELL THEM YOU PRACTICE UNIVERSAL SCREENING! Techniques to Evaluate for signs of addiction in your pain patient Michigan Automated Prescription System (MAPS) Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability A 23 year old was transferred from Midland for a complicated pregnancy termination. Successful dilation and evacuation was performed under laparoscopic guidance. Postoperatively, the patient complained of severe pain, prompting workup for bowel perforation. The patient requested high doses of IV Dilaudid for pain control Carl Christensen, MD PhD 5
6 Techniques to Evaluate for signs of addiction in your pain patient Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability Techniques to Evaluate for signs of addiction in your pain patient How do you make the diagnosis of addiction? Review of Medical Records (refusal?) Physical exam: Stigmata of addiction: nicotine, opiates, cocaine Obvious intoxication/withdrawal UDS MAPS Family interviews Multiple visits, evaluate for reliability Rule out a pure pain diagnosis You can have both!!!! Rule out malingering (selling) Use the DSM IV criteria or the 4 C s: (Craving, Compulsion, loss of Control & use despite Consequences) Keep asking yourself if you made the right diagnosis Doctor, am I going to become addicted? Overall: the incidence of iatrogenic addiction in the chronic pain patient is low. The initial estimate was 1/1000!!! BUT: The incidence of addiction in the chronic pain population is similar to the general population (15%). SO: EXPECT >5% OF YOUR PATIENTS TO SHOW ABERRANT BEHAVIOR ADDICTION PAIN What do you do when you realize you are fueling addiction rather than treating pain? Aronoff, 2000; Heit, 2004; Porter, Carl Christensen, MD PhD 6
7 Do NOT continue to prescribe! TREATMENT OF ADDICTION Impression: Opioid dependence Plan: Methadone 10 mg tabs, #240, return one month. Behavioral: counseling Spiritual: 12 step meetings Surgical: gastric bypass surgery MEDICAL 60 Physiology of Addiction 61 Agonists vs. Antagonists BOTTOM LINE: Drug Type Analogy Methadone Full Agonist High Octane Buprenorphine Partial Agonist Low Octane Naltrexone Antagonist Water 64 In both controlled and retrospective studies, the success rate for most medications is between 40 and 60% (one to two years). When patients come off the medication, they relapse. Relapse may be associated with an increased chance of overdose and death. Physiology of Addiction 65 Ball 1988: reduction in IVDU Ball 1988: resumption of IVDU! ORT: yes or no??? 67 ORT: yes or no??? 68 Carl Christensen, MD PhD 7
8 Buprenorphine ( Suboxone ) Buprenorphine A partial opiate agonist (less potent) Less analgesic effect Less respiratory depression <100 documented deaths in the U.S. (Soyka); PER YEAR WITH METHADONE Treats both pain and opiate dependency Different formulations are approved Available in 3 forms: Burpenex : injectable Subutex : sublingual buprenorphine* OFF MARKET Suboxone : sublingual buprenorphine + naloxone (Narcan ): prevents IV use* Will precipitate sudden withdrawal: only give when patient is going INTO withdrawal! * not FDA approved for pain Addiction and Pregnancy 72 Addiction and Pregnancy 73 Buprenorphine long-term follow up: Fiellin, 2008 Concerns about Suboxone It can be abused (mostly for withdrawal) It is unsafe when combined with sedatives & alcohol. It is an opioid. Relapse rates after detox exceed 90%. (Weiss, 2011) 75 Doc, when can I get off this sh*t medication? Can you detox? 101 women underwent detox during pregnancy 40 successfully detoxed. No adverse fetal effects documented Luty et al, J Sub Abuse Treat 24 (2003); ORT: yes or no??? 82 Carl Christensen, MD PhD 8
9 Detoxing During Pregnancy? Luty women underwent detox during pregnancy 40 successfully detoxed. No adverse fetal effects documented But: only 1/101 patients documented to be abstinent at time of delivery! Luty et al, J Sub Abuse Treat 24 (2003); ORT: yes or no??? 83 Maintenance vs. Detox? 40 heroin addicts were started on Suboxone. 20 were detoxed off and offered counseling. 20 were kept on Suboxone and offered counseling. A year later. ORT: yes or no??? ORT : yes or no??? 86 ORT : yes or no??? Treatment of Opioid Dependence During Pregnancy Maternal Opioid Treatment: Human Experimental Research (MOTHER) Carl Christensen, MD PhD 9
10 MOTHER STUDY MOTHER STUDY Double blinded, RCT Methadone vs. buprenorphine Contingency management (financial incentives) CBT Transportation, etc. NO polysubstance dependence x Patients already on methadone are admitted to research unit for detox 6 mg MS/mg methadone (4 divided doses) Rescue doses prn Kept until stabilized THIS IS NOT FEASIBLE IN CLINICAL PRACTICE!!!!!!!!! Randomized to study meds on L & D tobacco! Addiction and Pregnancy 90 Addiction and Pregnancy 89 Sites Johns Hopkins, Baltimore MD T. Jefferson Univ., Philadelphia, PA Women & Infants, Providence RI Vanderbilt UMC, Nashville, TN St. Joseph s Hlth Ctr. Toronto, Canada Wayne State Univ., Detroit, Michigan University of VT, Burlington, VT Addiction Clinic Vienna, Austria Addiction and Pregnancy 91 Addiction and Pregnancy 92 Methadone vs. Buprenorphine: the MOTHER study Measure Methadone Buprenorphine Amount of MS required # of days in hospital Duration of treatment for NAS Birthweight % preterm delivery 19 7* Positive drug screen at delivery 15% 9%* Dropped out 18% 33 MOTHER study. Buprenorphine exposed neonates exhibited fewer stress-abstinence signs, were less excitable less hypertonia better self-regulation and required less handling than methadone-exposed neonates. Jones Finnegan & Kaltenbach Drugs 2012 Addiction and Pregnancy Carl Christensen, MD PhD 10
11 Who should NOT go on buprenorphine? Patients who are: How do you start buprenorphine? Already on methadone (>35 mg) Unable to engage in treatment Taking benzos Plan on mixing bup with their opiates Are diverting Can t get insurance coverage Addiction and Pregnancy 95 LFT, UDS, informed consent If GA > 24 weeks: monitor on L&D Short acting opioids: 8 to 12 hrs abstinence or moderate withdrawal sx Start buprenex 0.3 mg IM q 6 scheduled Switch to 2 4 mg bupx sublingual DC on 8 to 16 mg bupx sublingual Addiction and Pregnancy 96 Methadone à Buprenorphine? Methadone: Has a LONG half life MOTHER study dropouts were due to attempts to convert high dose methadone to buprenorphine Current expert opinion is to limit to patients on mg. Safest course may be to remain on methadone. Labor/Surgery in Pregnant Patients on Buprenorphine: Options Planned delivery: convert to short acting opiates and back again Stop buprenorphine, start short acting opioids at any time. Resume buprenorphine after 12 hrs abstinence No opiates, rely on epidural (vag delivery only) Continue treatment with Buprenex SL Buprenorphine/Buprenex have been used postoperatively Addiction and Pregnancy 98 Addiction and Pregnancy 99 MARIJUANA AND PREGNANCY MARIJUANA AND PREGNANCY Addiction and Pregnancy 100 Occasional MJ use does not appear to affect birthweight, gestational age, etc. Heavy (weekly) users had babies with decreased birthweight. Babies MAY have shown withdrawal type symptoms at birth. No increase in abruption, SIDS, etc that you do see in tobacco addiction. Addiction and Pregnancy 101 Carl Christensen, MD PhD 11
12 MARIJUANA AND PREGNANCY MARIJUANA AND PREGNANCY ADOLESCENT use is associated with: Increased in schizophrenia (2x) Decreased IQ scores (8 points!) Congnitive deficits. Increase in psychiatric co morbidity Addiction and Pregnancy 102 Medical MJ is not (automatically) recognized by CPS. Referral and interventions may still occur. Medical MJ does not invalidate an addiction evaluation. Medical MJ does not prevent criminal prosecution for MVA, etc. Addiction and Pregnancy 103 Tobacco and Pregnancy Tobacco and Pregnancy Tobacco is a major cause of statistics Herb Malinoff, MD Addiction and Pregnancy 105 Addiction and Pregnancy 106 Tobacco and Pregnancy Associated With: Low Birth Weight (LBW) Small for Gestational Age (SGA) Miscarriage Stillbirth SIDS Congenital anomalies* Difficulty Breastfeeding Addiction and Pregnancy 107 What works for tobacco cessation? (everyone) Counseling NRT Buproprion (Wellbutrin, Zyban) Buproprion + NRT Varenicline (Chantix) Addiction and Pregnancy 108 Carl Christensen, MD PhD 12
13 What works for tobacco cessation in pregnancy? Treatment Counseling NRT Buproprion (Zyban, Wellbutrin SR) Varenicline (Chantix) Outcome 14 vs 6 abstinent No success in pregnant women 45% vs 14% abstinent No data in pregnancy, 40+% success in nonpregnant patient. Addiction and Pregnancy 109 EHRC These medications are mostly category C: birth defects cannot be ruled out. Tobacco is Category X ( same as plutonium ) NRT, Buproprion and Varenicline are offered to all patients in 2 nd / 3 rd trimester. Addiction and Pregnancy 110 Management of Labor/Postpartum in the Recovering Patient Management of Labor/Postpartum in the Recovering Patient Labor may be a trigger for relapse Epidurals should be encouraged Don t discharge patients with short acting opiates whenever possible! For C/S patients: need to involve family, social work, EHRC when dispensing opiates RESIDENTS: Confirm EVERYTHING Labor may be a trigger for relapse Epidurals should be encouraged Don t discharge patients with short acting opiates whenever possible! For C/S patients: need to involve family, social work, EHRC when dispensing opiates RESIDENTS: Confirm EVERYTHING the patient tells you!! the patient tells you!! Addiction and Pregnancy Addiction and Pregnancy Management of Labor/Postpartum in the Recovering Patient Management of Labor/Postpartum in the Recovering Patient Labor may be a trigger for relapse Epidurals should be encouraged Don t discharge patients with short acting opiates whenever possible! For C/S patients: need to involve family, social work, EHRC when dispensing opiates RESIDENTS: Confirm EVERYTHING Labor may be a trigger for relapse Epidurals should be encouraged Don t discharge patients with short acting opiates whenever possible! For C/S patients: need to involve family, social work, EHRC when dispensing opiates RESIDENTS: Confirm EVERYTHING the patient tells you!! the patient tells you!! Addiction and Pregnancy Addiction and Pregnancy Carl Christensen, MD PhD 13
14 Management of Labor/Postpartum in the Recovering Patient Labor may be a trigger for relapse Epidurals should be encouraged Don t discharge patients with short acting opiates whenever possible! For C/S patients: need to involve family, social work, EHRC when dispensing opiates RESIDENTS: Confirm EVERYTHING the patient tells you!! Addiction and Pregnancy 115 Is there Recovery after Delivery? Is There Recovery After Delivery? Is There Recovery After Delivery? Relapse rates on tobacco are up to 85% after delivery. Normal relaspe rates for drugs and alcohol at one year are 40 to 60% for successful treatment. There is no evidence that a newborn is protective against relapse. The stressors of a newborn may predispose to relapse. Addiction and Pregnancy 119 Pregnancy is felt to be a window of opportunity in addiction treatment Often described as a gun to the head by the patient Patients are faced with loss of custody (of ALL children) if they test positive If they do not succeed, prognosis felt to be hopeless Addiction and Pregnancy 121 Is There Recovery After Delivery? Is There Recovery After Delivery? Addiction and Pregnancy 122 Addiction and Pregnancy 123 Carl Christensen, MD PhD 14
15 Why Treat Addiction? Drug Dependence, a Chronic Medical Illness: McLellan 2000 Only about 40% of patients will be abstinent at one year after treatment. Failure rates may be due to lack of aftercare, often due to insurance difficulties Low economic status, psych comorbidity and lack of family/social supports also predict relapse. Relapse is often viewed as inevitable and drug dependence as hopeless * Drug Dependence, a Chronic Medical Illness: McLellan 2000 Chronic, Treatable but Incurable Diseases ONLY 60% OF TYPE I DIABETICS ADHERE TO MEDICATION SCHEDULE LESS THAN 40% OF ASTHMATICS ADHERE TO TREATMENT REGIMEN LESS THAN 40% OF HYPERTENSIVES ADHERE TO THEIR TREATMENT REGIMEN DRUG DEPENDENCE =40 TO 60% ADHERENCE Obesity Hypertension Diabetes Asthma Addiction 126 Physiology of Addiction 128 Contact info: Carl Christensen YOUTUBE.COM: ccmdphd ccmdphd@mac.com Cell: Voice mail: Pain Recovery Solutions (A2): Physiology of Addiction 130 Carl Christensen, MD PhD 15
Disclaimers. RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It? What is Addiction? What is Addiction?
RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It? Disclaimers Consultant, PCSS Consultant, DEA/DOJ Consultant, BCBS Speaker, Reckitt Benckiser Carl Christensen,
More informationOpioid Replacement Therapy (ORT): Yes or No?
Opioid Replacement Therapy (ORT): Yes or No? Carl Christensen, MD, PhD, FASAM Associate Professor, Dept OB Gyn, WSU (retd) Medical Director, Addiction Medicine Services, DMC Past Chair, Michigan Health
More informationPregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research
Pregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research Hendree E. Jones Associate Professor, Department of Psychiatry Johns Hopkins University Outline I. World view
More informationHow to Recognize Addiction in your (chronic) Pain Patients
How to Recognize Addiction in your (chronic) Pain Patients Carl Christensen, MD PhD, FASAM Associate Prof, Depts of Psychiatry & OB Gyn, WSU President, Mich Society of Addiction Medicine Pain Recovery
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationSubstance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
More informationIdentifying and Managing Substance Use During Pregnancy
Identifying and Managing Substance Use During Pregnancy Joseph B. Landwehr, Jr., MD Director, Perinatal Center IU Health Ball Memorial Hospital OBJECTIVES Overview of illicit drug use in pregnant women
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More information5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationOpioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015
Q: I have read 40 mg of methadone stops withdrawal, so why don t we start at 30mg and maybe later in the day add 10mg? A: Federal Regulations stipulate that 30mg is the maximum first dose in an Opioid
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationSouthlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
More informationSubstance Abuse lifestyle Concern for mother - fetus - and - neonate
OBJECTIVES Learn about types of opioids and associated withdrawal symptoms Learn what medications are available to treat opioid addiction Understand the pros and cons associated with each medication Understand
More informationJoel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationDeveloping Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse
Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine
More informationIn 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
More informationThe Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
More informationKarol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University
Benzodiazepines and the Pregnant Patient: Special Challenges Karol Kaltenbach, PhD Maternal Addiction Treatment Education and Research Jefferson Medical College Thomas Jefferson University Outline Introduction
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
More informationConceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationMethadone and Pregnancy
Methadone and Pregnancy Methadone 101/Hospitalist Workshop Launette Rieb, MD, MSc, CCFP, CCSAM, FCFP Clinical Associate Professor, Dept. Family Practice, UBC American Board of Addiction Medicine Certified
More informationPain, Addiction & Methadone
Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationAddressing Substance Use in Pregnancy
Addressing Substance Use in Pregnancy Stefan Maxwell, MD Director, NICU, CAMC Women and Children s Hospital Chair, Drug Use in Pregnancy Committee West Virginia Perinatal Partnership July 31, 2013 WV Early
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationAdvanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
More informationUse of Buprenorphine in the Treatment of Opioid Addiction
Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an
More informationPutting Addiction Treatment Medications to Use: Lessons Learned
Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationUsing Buprenorphine in an Opioid Treatment Program
Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationUnderstanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders
Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I
More informationARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More informationCollaborative Care for Pregnant Women with Substance Use Disorders
Collaborative Care for Pregnant Women with Substance Use Disorders Alane O Connor DNP Maine Dartmouth Family Medicine Residency MaineGeneral Medical Center Dartmouth Medical School Vanderbilt University
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationMedication Assisted Treatment of Substance Use Disorders
Medication Assisted Treatment of Substance Use Disorders April 8, 2015 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary Care
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationPatients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
More informationProfessional Intervention and Treatment Related to Opioid Misuse and Addiction
Professional Intervention and Treatment Related to Opioid Misuse and Addiction Michael M. Miller, MD, FASAM, FAPA Drug Poisoning Summit: Stop the Overdose Epidemic January 30, 2012 University of Wisconsin
More informationAllyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
More informationDisclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationUse of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
More informationFinancial Disclosures
Opioid Agonist Therapy: To Maintain or Not To Maintain - A Case Discussion PCSS-MAT American Psychiatric Association Drs. Ed Salsitz, John Renner, Timothy Fong April 14, 2015 Financial Disclosures Edwin
More informationHeroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
More informationPrescription Drug Abuse: Recognition, Intervention, and Prevention
Prescription Drug Abuse: Recognition, Intervention, and Prevention Nicholas Reuter Division of Pharmacologic Therapy Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration
More informationPatient Information and Consent to Treatment with Buprenorphine
1063 Lower Main St, Ste C212 JEFFREY H. CHESTER, DO Phone 808.249.8887-6006 www.ponohealthcare.com Board Certified by American Board of Physical Medicine & Rehabilitation Board Certified by American Society
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationProvider enews TREATING PRESCRIPTION DRUG ADDICTION
Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options
More informationUnderstanding Addiction: The Intersection of Biology and Psychology
Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November
More informationAdvances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014
Advances in Addiction Science and Treatment Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Treatment Research Research Institute, Institute, 20132012 Presentation 1. What is driving
More informationGuidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
More informationAcute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationEXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org
EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution
More informationEstablished in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
More informationBuprenorphine: what is it & why use it?
Buprenorphine: what is it & why use it? Dr Nicholas Lintzeris, MBBS, PhD, FAChAM Locum Consultant, Oaks Resource Centre, SLAM National Addiction Centre, Institute of Psychiatry Overview of presentation
More informationMEDICAL POLICY Treatment of Opioid Dependence
POLICY........ PG-0313 EFFECTIVE......11/11/14 LAST REVIEW... 07/14/15 MEDICAL POLICY Treatment of Opioid Dependence GUIDELINES This policy does not certify benefits or authorization of benefits, which
More informationTriage, Assessment & Treatment
Triage, Assessment & Treatment Launette Rieb, MSc, MD, CCFP, FCFP, dip ABAM Clinical Associate Professor, Dept. Family Practice, UBC Physician Director, St. Paul's Hospital Goldcorp Addiction Medicine
More informationMedication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment
Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationGoals! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Addiction Vs! Dependence! The best laid If a tree falls!
Goals! Screening for Addiction and Dependence! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Implementing a Pain Contract! Narcotics & Pain Management in Addiction!
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationWelcome. How Do I Ask Questions? Agenda. Thank you for joining us today. The webinar will begin in a few moments.
Welcome How Do I Ask Questions? Thank you for joining us today. The webinar will begin in a few moments. If you are experiencing technical problems with the GoToWebinar program, contact the GoToWebinar
More informationSUPPORTING WOMEN USING OPIATES IN PREGNANCY: A Guideline for Primary Care Providers May, 2011
INTRODUCTION SUPPORTING WOMEN USING OPIATES IN PREGNANCY: A Guideline for Primary Care Providers May, 2011 Prevalence of Opiate Use and Impact on Maternal, Fetal, and Neonatal Health: The prevalence of
More information